{"id":13440,"date":"2024-03-17T09:49:40","date_gmt":"2024-03-17T09:49:40","guid":{"rendered":"https:\/\/www.gruenhorn.group\/?p=13440"},"modified":"2024-08-01T10:15:37","modified_gmt":"2024-08-01T10:15:37","slug":"neue-somai-cannabisextrakte-aus-portugal-fuer-deutsche-patienten","status":"publish","type":"post","link":"https:\/\/www.gruenhorn.group\/en\/neue-somai-cannabisextrakte-aus-portugal-fuer-deutsche-patienten\/","title":{"rendered":"Innovative SOMA\u00cd Cannabis extracts from Portugal for the German Market"},"content":{"rendered":"

The Gr\u00fcnhorn network paves the way for medical cannabis extracts from SOMA\u00cd Pharmaceuticals in Portugal to enter the German market.<\/strong><\/p>\n\n\n\n

In the course of the global discussion on cannabis, the increasing importance of cannabis extracts for shaping the modern medical landscape is becoming increasingly apparent. Consumption without inhalation is particularly attractive for health-conscious patients and doctors as extracts become of higher quality.<\/p>\n\n\n\n

SOMA\u00cd in partnership with Gr\u00fcnhorn is launching the first products of its broad innovative portfolio in Germany. Gr\u00fcnhorn, Germany's largest cannabis network, is expanding its portfolio with the products from Portugal. At Gr\u00fcnhorn Pharmacy, the extracts are available on prescription for patients starting from March 18, and through our wholesaler canymed.com for pharmacies across Germany: \"I am excited about SOMA\u00cd's expertise as a cutting-edge extract manufacturer within our Gr\u00fcnhorn network,<\/em>\" says Stefan Fritsch, founder of the Gr\u00fcnhorn network. \"The partnership aligns with our mission to provide patients access to diverse and innovative cannabis extracts.\"<\/em><\/p>\n\n\n\n

New extracts in the Gr\u00fcnhorn Portfolio<\/strong><\/p>\n\n\n\n

The product line offers patients in Germany a selection of medical formulations made from cannabinoids, terpenes, and flavonoids with varying THC and CBD content (including 25:1, 10:10, 2,5:25 and 25:25 ratios). The special thing about these extracts is that they are carefully purified: SOMA\u00cd's extraction method preserves the medically effective components of the respective variety. Plant components in the cannabis flower without scientifically proven therapeutic value, such as lipids, carbohydrates, chlorophyll, and polyphenols, are seperated up to 90% in the purification process. These components are responsible for the bitter taste in conventional crude oil extracts, which is eliminated. In short: desired substances are kept in the extract, while undesired substances are gently removed. Furthermore, consistent cultivars serve as the starting material for SOMA\u00cd extracts, ensuring high product stability. <\/p>\n\n\n\n

With the introduction of these innovative extracts in the German market, SOMA\u00cd and Gr\u00fcnhorn take another step towards modern forms of cannabis consumption. Michael Sassano, CEO of SOMA\u00cd Pharmaceuticals, states: \"I am proud that we can now offer our extracts in Germany with Germany\u2019s largest cannabis network. SOMA\u00cd has stabilized over 86 extracted SKU\u2019s and continues to produce more advanced formulas and delivery methods, for the most basic and advanced global cannabis markets. As German extract regulations progress, we hope to bring more of our full range of advanced products to doctors and patients.\u201d<\/em><\/p>\n\n\n\n

Background <\/strong><\/p>\n\n\n\n

Canymed GmbH, the pharmaceutical wholesaler of medical cannabis within the Gr\u00fcnhorn network, entered into a distribution and marketing agreement with SOMA\u00cd Pharmaceuticals. The collaboration combines canymed's expertise as a leading German medicinal cannabis company with the international experience of SOMA\u00cd Pharmaceuticals in developing personalized medications based on cannabis.<\/p>","protected":false},"excerpt":{"rendered":"

Das Gr\u00fcnhorn-Netzwerk ebnet medizinischen Cannabisprodukten von SOMA\u00cd Pharmaceuticals aus Portugal den Weg in den deutschen Markt. Im Zuge der \u00f6ffentlichen Diskussion \u00fcber Cannabis und der wachsenden Verbreitung von Cannabis-Therapien wird die Bedeutung von Extrakten f\u00fcr den modernen medizinischen Gebrauch deutlich. Die orale Einnahme von Cannabis wird besonders von \u00c4rztInnen und PatientInnen gesch\u00e4tzt, die das Inhalieren […]<\/p>\n","protected":false},"author":1,"featured_media":13699,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"_uag_custom_page_level_css":"","footnotes":""},"categories":[1],"tags":[],"class_list":["post-13440","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-pressemeldungen"],"uagb_featured_image_src":{"full":["https:\/\/www.gruenhorn.group\/wp-content\/uploads\/2024\/03\/Neue-SOMAI-Cannabisextrakte-aus-Portugal-fuer-deutsche-Patienten.webp",1200,601,false],"thumbnail":["https:\/\/www.gruenhorn.group\/wp-content\/uploads\/2024\/03\/Neue-SOMAI-Cannabisextrakte-aus-Portugal-fuer-deutsche-Patienten-150x150.webp",150,150,true],"medium":["https:\/\/www.gruenhorn.group\/wp-content\/uploads\/2024\/03\/Neue-SOMAI-Cannabisextrakte-aus-Portugal-fuer-deutsche-Patienten-300x150.webp",300,150,true],"medium_large":["https:\/\/www.gruenhorn.group\/wp-content\/uploads\/2024\/03\/Neue-SOMAI-Cannabisextrakte-aus-Portugal-fuer-deutsche-Patienten-768x385.webp",768,385,true],"large":["https:\/\/www.gruenhorn.group\/wp-content\/uploads\/2024\/03\/Neue-SOMAI-Cannabisextrakte-aus-Portugal-fuer-deutsche-Patienten-1024x513.webp",1024,513,true],"1536x1536":["https:\/\/www.gruenhorn.group\/wp-content\/uploads\/2024\/03\/Neue-SOMAI-Cannabisextrakte-aus-Portugal-fuer-deutsche-Patienten.webp",1200,601,false],"2048x2048":["https:\/\/www.gruenhorn.group\/wp-content\/uploads\/2024\/03\/Neue-SOMAI-Cannabisextrakte-aus-Portugal-fuer-deutsche-Patienten.webp",1200,601,false],"trp-custom-language-flag":["https:\/\/www.gruenhorn.group\/wp-content\/uploads\/2024\/03\/Neue-SOMAI-Cannabisextrakte-aus-Portugal-fuer-deutsche-Patienten.webp",18,9,false]},"uagb_author_info":{"display_name":"rsuessenbach","author_link":"https:\/\/www.gruenhorn.group\/en\/author\/rsuessenbach\/"},"uagb_comment_info":0,"uagb_excerpt":"Das Gr\u00fcnhorn-Netzwerk ebnet medizinischen Cannabisprodukten von SOMA\u00cd Pharmaceuticals aus Portugal den Weg in den deutschen Markt. Im Zuge der \u00f6ffentlichen Diskussion \u00fcber Cannabis und der wachsenden Verbreitung von Cannabis-Therapien wird die Bedeutung von Extrakten f\u00fcr den modernen medizinischen Gebrauch deutlich. Die orale Einnahme von Cannabis wird besonders von \u00c4rztInnen und PatientInnen gesch\u00e4tzt, die das Inhalieren…","_links":{"self":[{"href":"https:\/\/www.gruenhorn.group\/en\/wp-json\/wp\/v2\/posts\/13440"}],"collection":[{"href":"https:\/\/www.gruenhorn.group\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.gruenhorn.group\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.gruenhorn.group\/en\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/www.gruenhorn.group\/en\/wp-json\/wp\/v2\/comments?post=13440"}],"version-history":[{"count":2,"href":"https:\/\/www.gruenhorn.group\/en\/wp-json\/wp\/v2\/posts\/13440\/revisions"}],"predecessor-version":[{"id":13895,"href":"https:\/\/www.gruenhorn.group\/en\/wp-json\/wp\/v2\/posts\/13440\/revisions\/13895"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.gruenhorn.group\/en\/wp-json\/wp\/v2\/media\/13699"}],"wp:attachment":[{"href":"https:\/\/www.gruenhorn.group\/en\/wp-json\/wp\/v2\/media?parent=13440"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.gruenhorn.group\/en\/wp-json\/wp\/v2\/categories?post=13440"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.gruenhorn.group\/en\/wp-json\/wp\/v2\/tags?post=13440"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}